Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Jennifer Goldsack
CEO, DIGITAL MEDICINE SOCIETY (DIME)
Advancing Digital Health Innovation in the Gray Space of Evolving FDA Regulations: What to Expect in 2023 and Beyond
Ariane Gomes
CHIEF SCIENTIFIC OFFICER, BASEIMMUNE
Baseimmune
London, United Kingdom
Jennifer Good
CO-FOUNDER, PRESIDENT & CEO, TREVI THERAPEUTICS
Trevi Therapeutics, Inc.
New Haven, Connecticut, United States
Wyatt Gotbetter
SENIOR VICE PRESIDENT AND WORLDWIDE HEAD, ACCESS CONSULTING, PAREXEL
Tailored Regulatory and Access Strategies to Drive Cell and Gene Therapy Innovation and Value for Clinical Developers
Steven Gourlay, MBBS
CHIEF EXECUTIVE OFFICER, ACTINOGEN MEDICAL LIMITED
Actinogen Medical Limited
Sydney, New South Wales, Australia
J. Lance Grady
PRACTICE DIRECTOR, MARKET ACCESS, AVALERE HEALTH
The Inflation Reduction Act - A Market-Driven Event Impacting the Development of New Treatments
James Graham, Bcom
CEO, RECCE PHARMACEUTICALS LTD
Recce Pharmaceuticals (ASX: RCE, FSE: R9Q)
Sydney, Australia
Julie Gralow
CHIEF MEDICAL OFFICER AND EXECUTIVE VICE PRESIDENT, AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)
The Cancer Moonshot in Africa: Improving Cancer Patient Outcomes through Public-Private Partnerships
Amrie Grammer, PhD
FOUNDER, PRESIDENT, AMPEL BIOSOLUTIONS
AMPEL BioSolutions
Charlottesville, Virginia, United States
Rebecca Grant, JD
SENIOR DIRECTOR AND ASSOCIATE GENERAL COUNSEL, GENENTECH
Theoretical Patent Thickets v. Data-Driven Patent Policy: Are Changes Necessary at the PTO & FDA?
San Francisco, California, United States